Open AccessTreatment of Bronchopneumonia with Spiramycine (Rovamycine)
Author(s) -
Soejono,
Trastotenojo Ms,
N Harsoyo
Publication year - 2019
Publication title -
paediatrica indonesiana
Language(s) - English
Resource type - Journals
eISSN - 2338-476X
pISSN - 0030-9311
DOI - 10.14238/pi16.9-10.1976.396-402
Subject(s) - bronchopneumonia , medicine , pediatrics , body weight , staphylococcus aureus , biology , bacteria , genetics
Fifty-seven children with bronchopneumonia, comprising 32 male and 25 female, were admitted to the Department of Child Health, Dr. Kariadi Hospital, Semarang, during the period of May 1972 - May 1973. Varying in ages between 16 days and 7 years, 36 of them were less than one year old. They were treated with spiramycine (Rovamycine) given orally in a dosage of 50 mg/kg body weight daily in three divided doses. The failure was 9 out of 57 cases (15.8%) and in infants 7 out of 36 cases (19.4%). The culture of infants revealed 36.1% staphylococcus and in older children showed 4.8%. All cases of staphylococcus as a single cause which was treated with spiramycine gave good results. No side effects of spiramycine were noted. The study showed that spiramycine has a value in the treatment of childhood bronchopneumonia especially in staphylococcal injections in infants.